Charité project leader

Prof. Dr. Elisabeth Steinhagen-Thiessen

Chief Physician

Evangelisches Geriatriezentrum Berlin gGmbH

Reinickendorfer Str. 61

13347 Berlin

Phone   +49(0)30 4594-1900

Fax  +49(0)30 4594-1938

Email  elisabeth.steinhagen(at)egzb.de

Cooperation partners

Professor Dr. Ulman Lindenberger (Max Planck Institute for Education Research)

Dr. Wilfried Nietfeld (Max Planck Institute for Molecular Genetics)

Professor Dr. Gert G. Wagner (Socio-Economic Panel SOEP)

 

Berlin Aging Study II

Already in the early '90s, the Charité's Geriatric Research Group at the EGZB was involved in the Berlin Aging Study. This was a multidisciplinary study of senior citizens (aged 70 years and more) which provided important information about the health condition of Berlin's population.

A new version of the study, now called Berlin Aging Study II (BASE II) was launched in June 2009. With funds from the Federal Ministry of Education and Research, this study is being carried out together with Berlin's Max Planck Institute for Education Research, the Max Planck Institute for Molecular Genetics and the Socio-Economic Panel (SOEP).

The study intends to proceed with medical examinations of altogether about 2,200 citizens of Berlin, with half the participants consisting of young adults aged 20 to 30 years and the other half senior citizens aged 60 and more. The Charité's study leader Professor Dr. Elisabeth Steinhagen-Thiessen expects that this new version of the study will reveal the long-term changes in health between young and middle-aged adults and the transition into old age. Like its predecessor study, the Berlin Aging Study II consists of a long-term study with repeated health check-ups at intervals of several years.

The medical examinations include obtaining detailed information about all former and existing illnesses, a thorough medical examination by a doctor, together with laboratory analyses and examinations using various instruments and equipment. A special focus concentrates on the illnesses and the negative impacts on the state of health with the greatest influence on the burden of illness and quality of life at an advanced age. These include cardiovascular and pulmonary diseases, metabolic conditions, degenerative diseases of the central nervous system (dementia and Parkinson's), restricted mobility and the risk of falling, together with impaired sight and hearing. The Berlin Aging Study II also looks at everyday activities, sport and leisure, diet, the use of drugs and medication and subjective opinions about the quality of life and state of health.

PLEASE NOTE: Doctoral theses are still available in the Berlin Aging Study! You can find the current call for theses here: